Christopher K.  Scott net worth and biography

Christopher Scott Biography and Net Worth

CFO of Iradimed
Mr. Scott has served as our Chief Financial Officer and Corporate Secretary since December 2013. Mr. Scott has extensive experience in finance and accounting.  Mr. Scott held a management position at Darden Restaurants, Inc. from 2010 to 2013, where he provided accounting and reporting oversight.

From 2002 to 2010, Mr. Scott served as an auditor and senior manager at KPMG LLP. Mr. Scott received a B.S. in Accounting from the University of Central Florida in 2002.

What is Christopher K. Scott's net worth?

The estimated net worth of Christopher K. Scott is at least $1.73 million as of August 6th, 2018. Mr. Scott owns 32,398 shares of Iradimed stock worth more than $1,733,293 as of November 21st. This net worth estimate does not reflect any other assets that Mr. Scott may own. Learn More about Christopher K. Scott's net worth.

How do I contact Christopher K. Scott?

The corporate mailing address for Mr. Scott and other Iradimed executives is 1025 Willa Springs Dr., Winter Springs FL, 32708. Iradimed can also be reached via phone at (407) 677-8022 and via email at [email protected]. Learn More on Christopher K. Scott's contact information.

Has Christopher K. Scott been buying or selling shares of Iradimed?

Christopher K. Scott has not been actively trading shares of Iradimed in the last ninety days. Most recently, Christopher K. Scott sold 19,286 shares of the business's stock in a transaction on Friday, February 11th. The shares were sold at an average price of $50.06, for a transaction totalling $965,457.16. Learn More on Christopher K. Scott's trading history.

Who are Iradimed's active insiders?

Iradimed's insider roster includes Monty Allen (Director), James Hawkins (Director), Brent Johnson (VP), Christopher Scott (CFO), Roger Susi (CEO), and Anthony Vuoto (Director). Learn More on Iradimed's active insiders.

Are insiders buying or selling shares of Iradimed?

During the last year, insiders at the medical equipment provider sold shares 5 times. They sold a total of 20,249 shares worth more than $889,453.46. The most recent insider tranaction occured on December, 26th when CEO Roger E Susi sold 5,000 shares worth more than $230,000.00. Insiders at Iradimed own 37.1% of the company. Learn More about insider trades at Iradimed.

Information on this page was last updated on 12/26/2023.

Christopher K. Scott Insider Trading History at Iradimed

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/11/2022Sell19,286$50.06$965,457.16View SEC Filing Icon  
11/23/2021Sell26,715$40.98$1,094,780.70View SEC Filing Icon  
8/8/2018Sell96,250$26.05$2,507,312.5032,398View SEC Filing Icon  
8/6/2018Sell26,297$26.16$687,929.5232,398View SEC Filing Icon  
See Full Table

Christopher K. Scott Buying and Selling Activity at Iradimed

This chart shows Christopher K Scott's buying and selling at Iradimed by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Iradimed Company Overview

Iradimed logo
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with RALU ferromagnetic detection device. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.
Read More

Today's Range

Now: $53.50
Low: $52.35
High: $53.82

50 Day Range

MA: $50.81
Low: $46.74
High: $57.35

2 Week Range

Now: $53.50
Low: $40.05
High: $57.95

Volume

11,892 shs

Average Volume

48,770 shs

Market Capitalization

$677.85 million

P/E Ratio

36.64

Dividend Yield

1.17%

Beta

0.79